chloramphenicol has been researched along with Parkinson Disease in 7 studies
Amphenicol: Chloramphenicol and its derivatives.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (85.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, J | 1 |
Kim, SJ | 1 |
Ryu, MJ | 1 |
Jang, Y | 1 |
Lee, MJ | 1 |
Ju, X | 1 |
Lee, YL | 1 |
Cui, J | 1 |
Shong, M | 1 |
Heo, JY | 1 |
Kweon, GR | 1 |
Christensen, LK | 1 |
Skovsted, L | 1 |
Osuntokun, BO | 1 |
Bademosi, O | 1 |
Ogunremi, K | 1 |
Wright, SG | 1 |
Stefanis, CN | 2 |
Issidorides, M | 1 |
Cronkite, EP | 1 |
3 trials available for chloramphenicol and Parkinson Disease
Article | Year |
---|---|
Aberrant mRNA in Parkinsonism: support for hypothesis from studies with chloramphenicol.
Topics: Chloramphenicol; Clinical Trials as Topic; Female; Humans; Male; Parkinson Disease; RNA, Messenger | 1970 |
Chloramphenicol misuse.
Topics: Anemia, Aplastic; Chloramphenicol; Clinical Trials as Topic; Drug Hypersensitivity; Human Experiment | 1970 |
Chloramphenicol misuse.
Topics: Chloramphenicol; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Hypersensitivity; Human Expe | 1970 |
4 other studies available for chloramphenicol and Parkinson Disease
Article | Year |
---|---|
Chloramphenicol Mitigates Oxidative Stress by Inhibiting Translation of Mitochondrial Complex I in Dopaminergic Neurons of Toxin-Induced Parkinson's Disease Model.
Topics: Animals; Chloramphenicol; Disease Models, Animal; Herbicides; Humans; Mice; Mitochondria; Oxidative | 2019 |
Editorial: Miracle cures in Parkinson's disease.
Topics: Chloramphenicol; Cyclic AMP; Depression; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Dise | 1975 |
Inhibition of drug metabolism by chloramphenicol.
Topics: Aged; Biotransformation; Carbon Isotopes; Chloramphenicol; Chromatography, Thin Layer; Dicumarol; Hu | 1969 |
Neuropsychiatric manifestations of typhoid fever in 959 patients.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chloramphenicol; Female; Humans; Infant; Male; Men | 1972 |